Sirtex Medical Ltd (SRX):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Sirtex Medical Ltd (SRX) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12173
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sirtex Medical Ltd (Sirtex Medical) is a medical device company that develops and markets device for the treatment of liver cancer. The company’s sir-spheres microsphere is a medical device, which is used in selective internal radiation therapy for liver tumors. Its product Y-90 resin microspheres reside in the small blood vessels of the tumor where they destroy it from the inside while saving the surrounding healthy tissue. Sirtex Medical conducts studies, which include SIRFLOX and FOXFIRE Global for liver metastases, and RESIRT for primary renal cell carcinoma. The company has operations in Australia, New Zealand, Singapore, Germany, the US, Canada, and others. Sirtex Medical is headquartered in North Sydney, New South Wales, Australia.

Sirtex Medical Ltd (SRX) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sirtex Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sirtex Medical Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sirtex Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sirtex Medical Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Sirtex Medical Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sirtex Medical Ltd, Medical Equipment, Deal Details 10
Private Equity 10
CDH Investments and China Grand Pharma Plan to Acquire Sirtex Medical for USD1.43 Billion 10
Partnerships 12
Sirtex Medical Enters Into Co-Marketing Agreement With Surefire Medical For Infusion Systems 12
Acquisition 13
Varian Medical Systems to Acquire Sirtex Medical for USD1.285 Billion 13
Bayer May Acquire Sirtex Medical 15
Sirtex Medical Ltd – Key Competitors 16
Sirtex Medical Ltd – Key Employees 17
Sirtex Medical Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 20
Strategy And Business Planning 20
Jun 28, 2017: Sirtex Resets Business With Write Off Of Intangibles And Restructure 20
Financial Announcements 22
Aug 29, 2018: Sirtex records full year NPAT of $41.5 million 22
Feb 21, 2018: Sirtex records 1H18 NPAT of $ 23.6 million 24
Aug 23, 2017: Sirtex Records Underlying Full Year NPAT of $42.4 Million 25
Feb 22, 2017: Sirtex Records First Half NPAT of $20.8 Million 29
Corporate Communications 32
Sep 20, 2017: Mr Richard Hill to Retire as Chairman at Upcoming AGM 32
Sep 13, 2017: Helen Kurincic Joins the Sirtex Board as a Non-Executive Director 33
Jun 16, 2017: Sirtex CEO Andrew McLean Joins the Board of Directors 34
May 24, 2017: Sirtex Appoints Andrew McLean as Chief Executive Officer 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Sirtex Medical Ltd, Medical Equipment, Key Facts, 2018 2
Sirtex Medical Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Sirtex Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sirtex Medical Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sirtex Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sirtex Medical Ltd, Deals By Market, 2012 to YTD 2018 8
Sirtex Medical Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
CDH Investments and China Grand Pharma Plan to Acquire Sirtex Medical for USD1.43 Billion 10
Sirtex Medical Enters Into Co-Marketing Agreement With Surefire Medical For Infusion Systems 12
Varian Medical Systems to Acquire Sirtex Medical for USD1.285 Billion 13
Bayer May Acquire Sirtex Medical 15
Sirtex Medical Ltd, Key Competitors 16
Sirtex Medical Ltd, Key Employees 17
Sirtex Medical Ltd, Subsidiaries 18

List of Figures
Sirtex Medical Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Sirtex Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Sirtex Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Sirtex Medical Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Sirtex Medical Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sirtex Medical Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Sirtex Medical Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sirtex Medical Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Sirtex Medical Ltd (SRX):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hecla Mining Company:企業のM&A・事業提携・投資動向
    Hecla Mining Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hecla Mining Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • BYD Company Limited:企業の戦略・SWOT・財務情報
    BYD Company Limited - Strategy, SWOT and Corporate Finance Report Summary BYD Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Touchstone Exploration Inc (TXP):企業の財務・戦略的SWOT分析
    Summary Touchstone Exploration Inc (Touchstone), formerly Touchstone Resources Ltd is an upstream oil and gas exploration and production company that explores, produces, and develops, oil and gas properties in Trinidad and Tobago. The company holds interests, owns, and operates projects such as WD-4 …
  • Zhejiang Hisun Pharmaceutical Co Ltd (600267):企業の財務・戦略的SWOT分析
    Summary Zhejiang Hisun Pharmaceutical Co Ltd (Hisun) manufactures and commercializes drugs to treat tumor, infections, cardiovascular, endocrine, depression and orthopaedic disorders. The company’s product portfolio includes anti-tumor and anti-viral, hypoglycemic drugs, animal health products, oral …
  • TiGenix NV (TIG):企業の財務・戦略的SWOT分析
    Summary TiGenix NV (TiGenix), a subsidiary of Takeda Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and commercializes novel therapeutic products. The company exploits the anti-inflammatory properties of stem cells to develop novel therapies. It offers products such as AlloCSC-0 …
  • Occidental Petroleum Corporation (OXY)-エネルギー分野:企業M&A・提携分析
    Summary Occidental Petroleum Corporation (Occidental) is an oil and gas exploration and production company with integrated assets. The company is active in upstream exploration and production; midstream and marketing; and chemicals business. The oil and gas business explores for, develops and produc …
  • Connecticut Municipal Electric Energy Cooperative:企業の戦略的SWOT分析
    Connecticut Municipal Electric Energy Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competi …
  • A.P. Moller – Maersk AS (MAERSK B)-石油・ガス分野:企業M&A・提携分析
    Summary A.P. Moller - Maersk A/S (APM) is a business conglomerate that carries out operations in global trade, shipping and energy. It operates through a network of tankers, supply ships, container vessels, car carriers, drilling rigs and special vessels. The company also carries out container termi …
  • Moberg Pharma AB (MOB):企業の財務・戦略的SWOT分析
    Summary Moberg Pharma AB (Moberg Pharma), formerly Moberg Derma AB, is a pharmaceutical company. The company provides commercializes proprietary, acquired and licensed products. It provides treatment of skin diseases. Moberg Pharma treats fungal infection or psoriasis, discolored and fungus-damaged …
  • SS&C Technologies Holdings Inc.:企業のM&A・事業提携・投資動向
    SS&C Technologies Holdings Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SS&C Technologies Holdings Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Edison SpA (EDNR):電力:M&Aディール及び事業提携情報
    Summary Edison SpA (Edison), a subsidiary of Electricite de France S.A., is an energy company that explores, produces, develops and sells natural gas and crude oil in the Mediterranean Basin. The company generates and sells electricity; and develops, stores, transports and sells gas in Italy. Edison …
  • Bayerische Patentallianz GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Bayerische Patentallianz GmbH (Bayerische Patentallianz) is a central patent and marketing agency that evaluates and markets the inventions, protecting, marketing and achieving financial benefits. The agency provides support and consulting services to small and medium businesses and free inv …
  • BUCA, Inc.:企業の戦略・SWOT・財務情報
    BUCA, Inc. - Strategy, SWOT and Corporate Finance Report Summary BUCA, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Liebherr-International AG:企業の戦略・SWOT・財務分析
    Liebherr-International AG - Strategy, SWOT and Corporate Finance Report Summary Liebherr-International AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Carraro Spa:戦略・SWOT・企業財務分析
    Carraro Spa - Strategy, SWOT and Corporate Finance Report Summary Carraro Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Ohishi Sangyo Co., Ltd.:企業の戦略・SWOT・財務情報
    Ohishi Sangyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ohishi Sangyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • AB Science SA (AB)-製薬・医療分野:企業M&A・提携分析
    Summary AB Science SA (ABS) is a pharmaceutical company that discovers, develops and commercializes tyrosine kinase inhibitor. The company concentrates its research on inflammatory diseases, cancers and central nervous system diseases in human and veterinary medicine. Its masitinib is an orally admi …
  • Bellicum Pharmaceuticals Inc (BLCM):企業の財務・戦略的SWOT分析
    Summary Bellicum Pharmaceuticals, Inc. (Bellicum) is a clinical stage biopharmaceutical company, which is engaged in developing cellular immunotherapies for the treatment of cancer. The company develops its product candidates through its chemical induction of dimerization technology platforms in the …
  • Canadian Broadcasting Corp:企業の戦略的SWOT分析
    Canadian Broadcasting Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Marafiq:企業の発電所・SWOT分析2018
    Marafiq - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆